SEARCH

SEARCH BY CITATION

References

  • BACKSTROM, J.R., CHANG, M.S., CHU, H., NISWENDER, C.M. & SANDERS-BUSH, E.(1999). Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD). Neuropsychopharmacology, 21, 77S81S.
  • BERG, K.A., CLARKE, W.P., SAILSTAD, C., SALTZMAN, A. & MAAYANI, S.(1994). Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. Mol. Pharmacol., 46, 477484.
  • BERG, K.A., MAAYANI, S. & CLARKE, W.P.(1996). 5-hydroxytryptamine 2C receptor activation inhibits 5-hydroxytryptamine 1B-like receptor function via arachidonic acid metabolism. Mol. Pharmacol., 50, 10171023.
  • BERG, K.A., MAAYANI, S., GOLDFARB, J., SCARAMELLINI, C., LEFF, P. & CLARKE, W.P.(1998). Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol. Pharmacol., 54, 94104.
  • BERG, K.A., STOUT, B.D., CROPPER, J.D., MAAYANI, S. & CLARKE, W.P.(1999). Novel actions of inverse agonists on 5-HT2C receptor systems. Mol. Pharmacol., 55, 863872.
  • BRINK, C.B., WADE, S.M. & NEUBIG, R.R.(2000). Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: 1-isoproterenol selectively activates G(s). J. Pharmacol. Exp. Ther., 294, 539547.
  • BURNS, C.M., CHU, H., RUETER, S.M., HUTCHINSON, L.K., CANTON, H., SANDERS-BUSH, E. & EMESON, R.B.(1997). Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature, 387, 303308.
  • CHANG, M., ZHANG, L., TAM, J.P. & SANDERS-BUSH, E.(2000). Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides. Endogenous 5-HT(2C) receptors in choroid plexus epithelial cells. J. Biol. Chem., 275, 70217029.
  • CHENG, Y. & PRUSOFF, W.H.(1973). Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol., 22, 30993108.
  • CLARKE, W.P. & BOND, R.A.(1998). The elusive nature of intrinsic efficacy. Trends. Pharmacol. Sci., 19, 270276.
  • CONN, P.J., SANDERS-BUSH, E., HOFFMAN, B.J. & HARTIG, P.R.(1986). A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc. Natl. Acad. Sci. U.S.A., 83, 40864088.
  • CORDEAUX, Y., BRIDDON, S.J., MEGSON, A.E., MCDONNELL, J., DICKENSON, J.M. & HILL, S.J.(2000). Influence of receptor number on functional responses elicited by agonists acting at the human adenosine A(1) receptor: evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity. Mol. Pharmacol., 58, 10751084.
  • FITZGERALD, L.W., IYER, G., CONKLIN, D.S., KRAUSE, C.M., MARSHALL, A., PATTERSON, J.P., TRAN, D.P., JONAK, G.J. & HARTIG, P.R.(1999). Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology, 21, 82S90S.
  • FURCHGOTT, R.F.(1966). The use of ß-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. In Advances in Drug Research., ed. Harper, N.J. & Simmonds, A.B. pp. 2155. London: Academic Press.
  • GILES, H., LANSDELL, S.J., BOLOFO, M.L., WILSON, H.L. & MARTIN, G.R.(1996). Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding. Br. J. Pharmacol., 117, 11191126.
  • GOHLA, A., OFFERMANNS, S., WILKIE, T.M. & SCHULTZ, G.(1999). Differential involvement of Galpha12 and Galpha13 in receptor -mediated stress fiber formation. J. Biol. Chem., 274, 1790117907.
  • GUDERMANN, T., SCHONEBERG, T. & SCHULTZ, G.(1997). Functional and structural complexity of signal transduction via G - protein-coupled receptors. Annu. Rev. Neurosci., 20, 399427.
  • HALL, R.A., PREMONT, R.T. & LEFKOWITZ, R.J.(1999). Heptahelical receptor signaling: beyond the G protein paradigm. J. Cell. Biol., 145, 927932.
  • HERRICK-DAVIS, K., GRINDE, E. & NISWENDER, C.M.(1999). Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J. Neurochem., 73, 17111717.
  • KAUFMAN, M.J., HARTIG, P.R. & HOFFMAN, B.J.(1995). Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus. J. Neurochem., 64, 199205.
  • KENAKIN, T.(1995). Agonist-receptor efficacy II: agonist trafficking of receptor signals. Trends. Pharmacol. Sci., 16, 232238.
  • KENAKIN, T.(1997). Pharmacologic analysis of drug-receptor interaction. 3rd edition. New York: Raven Press.
  • MENGOD, G., PALACIOS, J.M., WIEDERHOLD, K.H. & HOYER, D.(1997). 5-hydroxytryptamine receptor histochemistry: Comparison of receptor mRNA distribution and radioligand autoradiography in the brain. In Serotonergic. Neurons and 5-HT Receptors in the CNS. ed. Baumgarten, H.G. & Gothert, M. pp. 213237. Berlin: Springer-Verlag.
  • NISWENDER, C.M., COPELAND, S.C., HERRICK-DAVIS, K., EMESON, R.B. & SANDERS-BUSH, E.(1999). RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J. Biol Chem., 274, 94729478.
  • ROBB, S., CHEEK, T.R., HANNAN, F.L., HALL, L.M., MIDGLEY, J.M. & EVANS, P.D.(1994). Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. EMBO J., 13, 13251330.
  • ROTH, B.L., WILLINS, D.L., KRISTIANSEN, K. & KROEZE, W.K.(1998). 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function. Pharmacol. Ther., 79, 231257.
  • SIMPSON, L. & EMESON, R.B.(1996). RNA editing. Annu. Rev. Neurosci., 19, 2752.
  • SMITH, H.C., GOTT, J.M. & HANSON, M.R.(1997). A guide to RNA editing. RNA, 3, 11051123.
  • SPENGLER, D., WAEBER, C., PANTALONI, C., HOLSBOER, F., BOCKAERT, J., SEEBURG, P.H. & JOURNOT, L.(1993). Differential signal transduction by five splice variants of the PACAP receptor. Nature, 365, 170175.